New combination treatments in the management of asthma: focus on fluticasone/vilanterol

Laren D Tan1 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA;2 Department of Medicine, Veterans Administration Northern California Health Care System, Mather, CA

Andrew L Chan1 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA;2 Department of Medicine, Veterans Administration Northern California Health Care System, Mather, CA

Timothy E Albertson1 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA;2 Department of Medicine, Veterans Administration Northern California Health Care System, Mather, CA;3 Department of Emergency Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USACorrespondence[email protected]

New combination treatments in the management of asthma: focus on fluticasone/vilanterol

Table 1 Currently available ICS/LABA inhalers

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

New combination treatments in the management of asthma: focus on fluticasone/vilanterol

Figures & data

Table 1 Currently available ICS/LABA inhalers

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date